Copyright Reports & Markets. All rights reserved.

Global Injection-grade Plant Derived Cholesterol Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Injection-grade Plant Derived Cholesterol Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity≥99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Injection-grade Plant Derived Cholesterol Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 mRNA Vaccines
    • 1.4.3 Gene Therapy
    • 1.4.4 Cell Culture
    • 1.4.5 Others
  • 1.5 Global Injection-grade Plant Derived Cholesterol Market Size & Forecast
    • 1.5.1 Global Injection-grade Plant Derived Cholesterol Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Injection-grade Plant Derived Cholesterol Sales Quantity (2020-2031)
    • 1.5.3 Global Injection-grade Plant Derived Cholesterol Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Evonik
    • 2.1.1 Evonik Details
    • 2.1.2 Evonik Major Business
    • 2.1.3 Evonik Injection-grade Plant Derived Cholesterol Product and Services
    • 2.1.4 Evonik Injection-grade Plant Derived Cholesterol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Evonik Recent Developments/Updates
  • 2.2 Hunan Kerey Pharmaceutical
    • 2.2.1 Hunan Kerey Pharmaceutical Details
    • 2.2.2 Hunan Kerey Pharmaceutical Major Business
    • 2.2.3 Hunan Kerey Pharmaceutical Injection-grade Plant Derived Cholesterol Product and Services
    • 2.2.4 Hunan Kerey Pharmaceutical Injection-grade Plant Derived Cholesterol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Hunan Kerey Pharmaceutical Recent Developments/Updates
  • 2.3 Croda Pharma (Avanti)
    • 2.3.1 Croda Pharma (Avanti) Details
    • 2.3.2 Croda Pharma (Avanti) Major Business
    • 2.3.3 Croda Pharma (Avanti) Injection-grade Plant Derived Cholesterol Product and Services
    • 2.3.4 Croda Pharma (Avanti) Injection-grade Plant Derived Cholesterol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Croda Pharma (Avanti) Recent Developments/Updates
  • 2.4 Merck
    • 2.4.1 Merck Details
    • 2.4.2 Merck Major Business
    • 2.4.3 Merck Injection-grade Plant Derived Cholesterol Product and Services
    • 2.4.4 Merck Injection-grade Plant Derived Cholesterol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Merck Recent Developments/Updates
  • 2.5 SINOPEG
    • 2.5.1 SINOPEG Details
    • 2.5.2 SINOPEG Major Business
    • 2.5.3 SINOPEG Injection-grade Plant Derived Cholesterol Product and Services
    • 2.5.4 SINOPEG Injection-grade Plant Derived Cholesterol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 SINOPEG Recent Developments/Updates
  • 2.6 Hunan Furui Biopharma
    • 2.6.1 Hunan Furui Biopharma Details
    • 2.6.2 Hunan Furui Biopharma Major Business
    • 2.6.3 Hunan Furui Biopharma Injection-grade Plant Derived Cholesterol Product and Services
    • 2.6.4 Hunan Furui Biopharma Injection-grade Plant Derived Cholesterol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Hunan Furui Biopharma Recent Developments/Updates
  • 2.7 Biopharma PEG
    • 2.7.1 Biopharma PEG Details
    • 2.7.2 Biopharma PEG Major Business
    • 2.7.3 Biopharma PEG Injection-grade Plant Derived Cholesterol Product and Services
    • 2.7.4 Biopharma PEG Injection-grade Plant Derived Cholesterol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Biopharma PEG Recent Developments/Updates
  • 2.8 IRIS BIOTECH GMBH
    • 2.8.1 IRIS BIOTECH GMBH Details
    • 2.8.2 IRIS BIOTECH GMBH Major Business
    • 2.8.3 IRIS BIOTECH GMBH Injection-grade Plant Derived Cholesterol Product and Services
    • 2.8.4 IRIS BIOTECH GMBH Injection-grade Plant Derived Cholesterol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 IRIS BIOTECH GMBH Recent Developments/Updates

3 Competitive Environment: Injection-grade Plant Derived Cholesterol by Manufacturer

  • 3.1 Global Injection-grade Plant Derived Cholesterol Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Injection-grade Plant Derived Cholesterol Revenue by Manufacturer (2020-2025)
  • 3.3 Global Injection-grade Plant Derived Cholesterol Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Injection-grade Plant Derived Cholesterol by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Injection-grade Plant Derived Cholesterol Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Injection-grade Plant Derived Cholesterol Manufacturer Market Share in 2024
  • 3.5 Injection-grade Plant Derived Cholesterol Market: Overall Company Footprint Analysis
    • 3.5.1 Injection-grade Plant Derived Cholesterol Market: Region Footprint
    • 3.5.2 Injection-grade Plant Derived Cholesterol Market: Company Product Type Footprint
    • 3.5.3 Injection-grade Plant Derived Cholesterol Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Injection-grade Plant Derived Cholesterol Market Size by Region
    • 4.1.1 Global Injection-grade Plant Derived Cholesterol Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Injection-grade Plant Derived Cholesterol Consumption Value by Region (2020-2031)
    • 4.1.3 Global Injection-grade Plant Derived Cholesterol Average Price by Region (2020-2031)
  • 4.2 North America Injection-grade Plant Derived Cholesterol Consumption Value (2020-2031)
  • 4.3 Europe Injection-grade Plant Derived Cholesterol Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Injection-grade Plant Derived Cholesterol Consumption Value (2020-2031)
  • 4.5 South America Injection-grade Plant Derived Cholesterol Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Injection-grade Plant Derived Cholesterol Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Injection-grade Plant Derived Cholesterol Sales Quantity by Type (2020-2031)
  • 5.2 Global Injection-grade Plant Derived Cholesterol Consumption Value by Type (2020-2031)
  • 5.3 Global Injection-grade Plant Derived Cholesterol Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Injection-grade Plant Derived Cholesterol Sales Quantity by Application (2020-2031)
  • 6.2 Global Injection-grade Plant Derived Cholesterol Consumption Value by Application (2020-2031)
  • 6.3 Global Injection-grade Plant Derived Cholesterol Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Injection-grade Plant Derived Cholesterol Sales Quantity by Type (2020-2031)
  • 7.2 North America Injection-grade Plant Derived Cholesterol Sales Quantity by Application (2020-2031)
  • 7.3 North America Injection-grade Plant Derived Cholesterol Market Size by Country
    • 7.3.1 North America Injection-grade Plant Derived Cholesterol Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Injection-grade Plant Derived Cholesterol Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Injection-grade Plant Derived Cholesterol Sales Quantity by Type (2020-2031)
  • 8.2 Europe Injection-grade Plant Derived Cholesterol Sales Quantity by Application (2020-2031)
  • 8.3 Europe Injection-grade Plant Derived Cholesterol Market Size by Country
    • 8.3.1 Europe Injection-grade Plant Derived Cholesterol Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Injection-grade Plant Derived Cholesterol Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Injection-grade Plant Derived Cholesterol Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Injection-grade Plant Derived Cholesterol Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Injection-grade Plant Derived Cholesterol Market Size by Region
    • 9.3.1 Asia-Pacific Injection-grade Plant Derived Cholesterol Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Injection-grade Plant Derived Cholesterol Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Injection-grade Plant Derived Cholesterol Sales Quantity by Type (2020-2031)
  • 10.2 South America Injection-grade Plant Derived Cholesterol Sales Quantity by Application (2020-2031)
  • 10.3 South America Injection-grade Plant Derived Cholesterol Market Size by Country
    • 10.3.1 South America Injection-grade Plant Derived Cholesterol Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Injection-grade Plant Derived Cholesterol Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Injection-grade Plant Derived Cholesterol Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Injection-grade Plant Derived Cholesterol Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Injection-grade Plant Derived Cholesterol Market Size by Country
    • 11.3.1 Middle East & Africa Injection-grade Plant Derived Cholesterol Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Injection-grade Plant Derived Cholesterol Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Injection-grade Plant Derived Cholesterol Market Drivers
  • 12.2 Injection-grade Plant Derived Cholesterol Market Restraints
  • 12.3 Injection-grade Plant Derived Cholesterol Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Injection-grade Plant Derived Cholesterol and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Injection-grade Plant Derived Cholesterol
  • 13.3 Injection-grade Plant Derived Cholesterol Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Injection-grade Plant Derived Cholesterol Typical Distributors
  • 14.3 Injection-grade Plant Derived Cholesterol Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Injection-grade Plant Derived Cholesterol market size was valued at US$ 126 million in 2024 and is forecast to a readjusted size of USD 274 million by 2031 with a CAGR of 11.9% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Injection-grade plant derived cholesterol is obtained through a sophisticated process. It is either extracted from plants or produced via bio-fermentation and multi-step chemical synthesis procedures, with phytosterols from plants as the starting material. The production process aims to convert these plant - based sterols into cholesterol with a high degree of purity and quality suitable for injection - based pharmaceutical products.
    This report is a detailed and comprehensive analysis for global Injection-grade Plant Derived Cholesterol market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Injection-grade Plant Derived Cholesterol market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
    Global Injection-grade Plant Derived Cholesterol market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
    Global Injection-grade Plant Derived Cholesterol market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
    Global Injection-grade Plant Derived Cholesterol market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Injection-grade Plant Derived Cholesterol
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Injection-grade Plant Derived Cholesterol market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik, Hunan Kerey Pharmaceutical, Croda Pharma (Avanti), Merck, SINOPEG, Hunan Furui Biopharma, Biopharma PEG, IRIS BIOTECH GMBH, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Injection-grade Plant Derived Cholesterol market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥98%
    Purity≥99%
    Market segment by Application
    mRNA Vaccines
    Gene Therapy
    Cell Culture
    Others
    Major players covered
    Evonik
    Hunan Kerey Pharmaceutical
    Croda Pharma (Avanti)
    Merck
    SINOPEG
    Hunan Furui Biopharma
    Biopharma PEG
    IRIS BIOTECH GMBH
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Injection-grade Plant Derived Cholesterol product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Injection-grade Plant Derived Cholesterol, with price, sales quantity, revenue, and global market share of Injection-grade Plant Derived Cholesterol from 2020 to 2025.
    Chapter 3, the Injection-grade Plant Derived Cholesterol competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Injection-grade Plant Derived Cholesterol breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Injection-grade Plant Derived Cholesterol market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Injection-grade Plant Derived Cholesterol.
    Chapter 14 and 15, to describe Injection-grade Plant Derived Cholesterol sales channel, distributors, customers, research findings and conclusion.

    Buy now